EverCommerce Announces Changes to Its Board Of Directors
DENVER, Sept. 20, 2024 (GLOBE NEWSWIRE) — EverCommerce Inc. (Nasdaq: EVCM) (the “Company”), a leading provider of SaaS solutions for […]
Haoxi Health Technology Limited Announces the Closing of a $12 Million Underwritten Follow-on Public Offering
BEIJING, Sept. 20, 2024 (GLOBE NEWSWIRE) — Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider […]
Middlesex Water Vice President G. Christian Andreasen to Participate in Upcoming Gabelli Funds PFAS Symposium
ISELIN, N.J., Sept. 20, 2024 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ:MSEX) has announced that its Vice President of Enterprise […]
Mondelēz International to Acquire Evirth, a China Leader in Fast-Growing Cakes and Pastries
Significantly expands Mondelēz investment in a China category leader for frozen-to-chilled cakes and pastries Meets rising demand for fresh, premium […]
Churchill Downs Incorporated 2024 Third Quarter Financial Results Conference Call Invitation
LOUISVILLE, Ky., Sept. 20, 2024 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company […]
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a […]
Gaxos.ai Inc. Announces Exercise of Warrants for $3.24 Million Gross Proceeds
Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial […]
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
– Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health […]
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative disease MIPLYFFA is […]
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) — TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC […]
